The pattern no single source sees

The Record

Everything the registers published, read the hour it lands.

Each line restates a public record and links to the original. No commentary and no judgement: when something here is a story, it moves to News with a journalist’s name on it.

4,946 records in the last 7 days6 registersUpdated hourly

SEC EDGAR: material events, stakes, listings, share offerings, annual and quarterly reports.

Showing Tuesday 1 September 2026. Back to the latest

Tuesday 1 September 2026

783 records
  1. 8-K

    Park Dental Partners, Inc. discloses a material cybersecurity incident

    Form 8-K, item 1.05.

  2. 8-K

    NovoCure Ltd discloses a material cybersecurity incident

    Form 8-K, items 1.05, 8.01. Also reported other events.

  3. 8-K

    IP Strategy Holdings, Inc. received a delisting or listing-standard notice

    Form 8-K, item 3.01.

  4. 8-K

    U.S. GoldMining Inc. received a delisting or listing-standard notice

    Form 8-K, item 3.01.

  5. 8-K

    XTI Aerospace, Inc. received a delisting or listing-standard notice

    Form 8-K, items 3.01, 7.01. Also made a Regulation FD disclosure.

  6. 8-K

    authID Inc. received a delisting or listing-standard notice

    Form 8-K, item 3.01.

  7. 8-K

    Crinetics Pharmaceuticals, Inc. received a delisting or listing-standard notice

    Form 8-K, items 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03. Also reports a change in control; completed an acquisition or disposal; ended a material agreement; reports a director or officer change; changed shareholders’ rights; amended its articles or bylaws.

  8. 8-K

    Barinthus Biotherapeutics plc. received a delisting or listing-standard notice

    Form 8-K, items 3.01, 8.01. Also reported other events.

  9. 8-K

    Borealis Foods Inc. received a delisting or listing-standard notice

    Form 8-K, items 3.01, 7.01. Also made a Regulation FD disclosure.

  10. 8-K

    CID Holdco, Inc. received a delisting or listing-standard notice

    Form 8-K, items 3.01, 7.01. Also made a Regulation FD disclosure.

  11. 8-K

    BioXcel Therapeutics, Inc. received a delisting or listing-standard notice

    Form 8-K, items 2.03, 3.01. Also took on a new financial obligation.

  12. 8-K

    IT Tech Packaging, Inc. changed its auditor

    Form 8-K, item 4.01.

  13. Delisting

    Nasdaq Stock Market LLC filed to remove Crinetics Pharmaceuticals, Inc. from listing

    Form 25-NSE, notice of removal from listing and registration.

  14. Delisting

    Nasdaq Stock Market LLC filed to remove BOXABL Inc. from listing

    Form 25-NSE, notice of removal from listing and registration.

  15. Delisting

    Nasdaq Stock Market LLC filed to remove NCS Multistage Holdings, Inc. from listing

    Form 25-NSE, notice of removal from listing and registration.

  16. Stake 13D

    New stake of 5% or more by a holder who may seek influence

    Schedule 13D naming Nutra Pharma Corp and Pure Raw Supplies, LLC.

  17. 8-K

    Red Robin Gourmet Burgers Inc completed an acquisition or disposal

    Form 8-K, items 2.01, 7.01. Also made a Regulation FD disclosure.

  18. 8-K

    Korn Ferry completed an acquisition or disposal

    Form 8-K, items 2.01, 3.02, 7.01. Also sold shares without registration; made a Regulation FD disclosure.

  19. 8-K

    Ryman Hospitality Properties, Inc. completed an acquisition or disposal

    Form 8-K, items 2.01, 7.01. Also made a Regulation FD disclosure.

  20. 8-K

    NCS Multistage Holdings, Inc. completed an acquisition or disposal

    Form 8-K, items 1.02, 2.01. Also ended a material agreement.

  21. 8-K

    Hornbeck Offshore Services, Inc. completed an acquisition or disposal

    Form 8-K, items 1.01, 1.02, 2.01, 2.03. Also entered a material agreement; ended a material agreement; took on a new financial obligation.

  22. 8-K

    Figure Technology Solutions, Inc. completed an acquisition or disposal

    Form 8-K, item 2.01.

  23. Stake 13D

    Updated stake of 5% or more by a holder who may seek influence

    Schedule 13D/A naming Concentra Group Holdings Parent, Inc. and Ortenzio Robert A.

  24. Stake 13D

    Updated stake of 5% or more by a holder who may seek influence

    Schedule 13D/A naming ATG Capital Opportunities Fund LP and Empery Digital Inc.

  25. Stake 13D

    Updated stake of 5% or more by a holder who may seek influence

    Schedule 13D/A naming Orthopediatrics Corp and Squadron Capital LLC.

  26. 8-K

    Hyperliquid Strategies Inc entered a material agreement

    Form 8-K, item 1.01.

  27. 8-K

    Rent the Runway, Inc. entered a material agreement

    Form 8-K, item 1.01.

  28. 8-K

    J.P. Morgan Real Estate Income Trust, Inc. entered a material agreement

    Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.

  29. 8-K

    Root, Inc. entered a material agreement

    Form 8-K, items 1.01, 3.02. Also sold shares without registration.

  30. 8-K

    Moderna, Inc. entered a material agreement

    Form 8-K, item 1.01.

  31. 8-K

    Millrose Properties, Inc. entered a material agreement

    Form 8-K, item 1.01.

  32. 8-K

    Revolution Medicines, Inc. entered a material agreement

    Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.

  33. 8-K

    Spire Inc entered a material agreement

    Form 8-K, item 1.01.

  34. 8-K

    Pennantpark Investment Corp entered a material agreement

    Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.

  35. 8-K

    Shuttle Pharmaceuticals Holdings, Inc. entered a material agreement

    Form 8-K, item 1.01.

  36. 8-K

    MSC Income Fund, Inc. entered a material agreement

    Form 8-K, items 1.01, 2.03, 8.01. Also took on a new financial obligation; reported other events.

  37. 8-K

    Valion Bio, Inc. entered a material agreement

    Form 8-K, items 1.01, 3.02, 5.02. Also reports a director or officer change; sold shares without registration.

  38. 8-K

    TPG Private Equity Opportunities, L.P. entered a material agreement

    Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.

  39. 8-K

    Kustom Entertainment, Inc. entered a material agreement

    Form 8-K, items 1.01, 3.02, 8.01. Also sold shares without registration; reported other events.

  40. 8-K

    Indaptus Therapeutics, Inc. entered a material agreement

    Form 8-K, item 1.01.

  41. 8-K

    Profusa, Inc. entered a material agreement

    Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.

  42. 8-K

    Raphael Pharmaceutical Inc. entered a material agreement

    Form 8-K, item 1.01.

  43. 8-K

    Andretti Acquisition Corp. II entered a material agreement

    Form 8-K, item 1.01.

  44. 8-K

    Caterpillar Financial Services Corp entered a material agreement

    Form 8-K, item 1.01.

  45. 8-K

    Applied Optoelectronics, Inc. entered a material agreement

    Form 8-K, item 1.01.

  46. 8-K

    Caterpillar Inc entered a material agreement

    Form 8-K, item 1.01.

  47. 8-K

    Chesapeake Utilities Corp entered a material agreement

    Form 8-K, item 1.01.

  48. 8-K

    Global Water Resources, Inc. entered a material agreement

    Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.

  49. 8-K

    BMO 2026-5C15 Mortgage Trust entered a material agreement

    Form 8-K, item 1.01.

  50. 8-K

    1st Franklin Financial Corp entered a material agreement

    Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.

  51. 8-K

    Calumet, Inc. /DE entered a material agreement

    Form 8-K, items 1.01, 7.01. Also made a Regulation FD disclosure.

  52. 8-K

    Mohawk Industries Inc reports a director or officer change

    Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.

  53. 8-K

    Willow Tree Capital Corp reports a director or officer change

    Form 8-K, item 5.02.

  54. 8-K

    Silver Bow Mining Corp. reports a director or officer change

    Form 8-K, item 5.02.

  55. 8-K

    Stark Novus Financial Inc. reports a director or officer change

    Form 8-K, item 5.02.

  56. 8-K

    Intellinetics, Inc. reports a director or officer change

    Form 8-K, item 5.02.

  57. 8-K

    Nixxy, Inc. reports a director or officer change

    Form 8-K, item 5.02.

  58. 8-K

    Yum Brands Inc reports a director or officer change

    Form 8-K, items 5.02, 7.01, 8.01. Also made a Regulation FD disclosure; reported other events.

  59. 8-K

    Mannatech Inc reports a director or officer change

    Form 8-K, item 5.02.

  60. 8-K

    Hartford Creative Group, Inc. reports a director or officer change

    Form 8-K, item 5.02.

  61. 8-K

    Otter Tail Corp reports a director or officer change

    Form 8-K, item 5.02.

  62. 8-K

    HWH International Inc. reports a director or officer change

    Form 8-K, items 5.02, 8.01. Also reported other events.

  63. 8-K

    Vertex Pharmaceuticals Inc / MA reports a director or officer change

    Form 8-K, item 5.02.

  64. 8-K

    Peoples Financial Services Corp. reports a director or officer change

    Form 8-K, item 5.02.

  65. 8-K

    Quantum Corp /DE/ reports a director or officer change

    Form 8-K, items 5.02, 8.01. Also reported other events.

  66. 8-K

    Mid Penn Bancorp Inc reports a director or officer change

    Form 8-K, items 5.02, 5.03. Also amended its articles or bylaws.

  67. 8-K

    Raymond James Financial Inc reports a director or officer change

    Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.

  68. 8-K

    Hycroft Mining Holding Corp reports a director or officer change

    Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.

  69. 8-K

    Invivyd, Inc. reports a director or officer change

    Form 8-K, item 5.02.

  70. 8-K

    Sprouts Farmers Market, Inc. reports a director or officer change

    Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.

  71. 8-K

    Exodus Movement, Inc. reports a director or officer change

    Form 8-K, item 5.02.

  72. 8-K

    Gitlab Inc. reports a director or officer change

    Form 8-K, items 2.02, 5.02, 7.01. Also published results; made a Regulation FD disclosure.

  73. 8-K

    Abpro Holdings, Inc. reports a director or officer change

    Form 8-K, item 5.02.

  74. 8-K

    American Battery Materials, Inc. reports a director or officer change

    Form 8-K, items 5.02, 8.01. Also reported other events.

  75. 8-K

    Callan JMB Inc. reports a director or officer change

    Form 8-K, item 5.02.

  76. 8-K

    CDT Equity Inc. reports a director or officer change

    Form 8-K, items 5.02, 5.07. Also reported shareholder vote results.

  77. 8-K

    Alamar Biosciences, Inc. reports a director or officer change

    Form 8-K, item 5.02.

  78. 8-K

    Aeternum Health, Inc. reports a director or officer change

    Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.

  79. 8-K

    Avis Budget Group, Inc. reports a director or officer change

    Form 8-K, item 5.02.

  80. 8-K

    Greenlight Capital RE, Ltd. reports a director or officer change

    Form 8-K, items 5.02, 8.01. Also reported other events.

  81. 8-K

    Franklin Covey Co reports a director or officer change

    Form 8-K, item 5.02.

  82. 8-K

    Fluence Energy, Inc. reports a director or officer change

    Form 8-K, items 5.02, 8.01. Also reported other events.

  83. 8-K

    Aptargroup, Inc. reports a director or officer change

    Form 8-K, item 5.02.

  84. 8-K

    Amrize Ltd reports a director or officer change

    Form 8-K, item 5.02.

  85. 8-K

    Barfresh Food Group Inc. reports a director or officer change

    Form 8-K, item 5.02.

  86. 8-K

    Flexible Solutions International Inc reports a director or officer change

    Form 8-K, items 5.02, 8.01. Also reported other events.

  87. 8-K

    Getaround, Inc reports a director or officer change

    Form 8-K, item 5.02.

  88. 8-K

    Federal Home Loan Bank of Pittsburgh took on a new financial obligation

    Form 8-K, item 2.03.

  89. 8-K

    Federal Home Loan Bank of Des Moines took on a new financial obligation

    Form 8-K, item 2.03.

  90. 8-K

    Federal Home Loan Bank of Atlanta took on a new financial obligation

    Form 8-K, item 2.03.

  91. 8-K

    Federal Home Loan Bank of Boston took on a new financial obligation

    Form 8-K, item 2.03.

  92. 8-K

    Federal Home Loan Bank of Chicago took on a new financial obligation

    Form 8-K, item 2.03.

  93. 8-K

    Federal Home Loan Bank of Cincinnati took on a new financial obligation

    Form 8-K, item 2.03.

  94. 8-K

    Federal Home Loan Bank of Dallas took on a new financial obligation

    Form 8-K, item 2.03.

  95. 8-K

    Federal Home Loan Bank of Indianapolis took on a new financial obligation

    Form 8-K, item 2.03.

  96. 8-K

    Federal Home Loan Bank of Topeka took on a new financial obligation

    Form 8-K, item 2.03.

  97. Offering

    SB Energy, Inc. filed to register new shares

    Form S-1, registration statement.

  98. Offering

    RainRock Acquisition Corp. filed to register new shares

    Form S-1, registration statement.

  99. Offering

    FingerMotion, Inc. filed to register new shares

    Form S-1, registration statement.

  100. 8-K

    LGL Group Inc changed shareholders’ rights

    Form 8-K, items 3.03, 5.03, 8.01. Also amended its articles or bylaws; reported other events.

  101. 8-K

    VistaOne, L.P. sold shares without registration

    Form 8-K, item 3.02.

  102. 8-K

    Remora Capital Corp sold shares without registration

    Form 8-K, item 3.02.

  103. 8-K

    Macquarie Energy Transition Infrastructure Fund, L.P. sold shares without registration

    Form 8-K, items 3.02, 7.01. Also made a Regulation FD disclosure.

  104. 8-K

    Alternus Clean Energy, Inc. changed shareholders’ rights

    Form 8-K, items 3.03, 5.03, 8.01. Also amended its articles or bylaws; reported other events.

  105. 8-K

    Andalusian Credit Company, LLC sold shares without registration

    Form 8-K, item 3.02.

  106. 8-K

    CNL Strategic Residential Credit, Inc. sold shares without registration

    Form 8-K, item 3.02.

  107. 8-K

    Caring Brands, Inc. sold shares without registration

    Form 8-K, items 3.02, 8.01. Also reported other events.

  108. 8-K

    Cottonwood Communities, Inc. sold shares without registration

    Form 8-K, item 3.02.

  109. Offering

    Three Lions Acquisition Corp. published a final prospectus

    Form 424B4, prospectus for a priced offering.

  110. Offering

    Advance JV Group Ltd published a final prospectus

    Form 424B4, prospectus for a priced offering.

  111. 8-K

    Regis Corp published results

    Form 8-K, item 2.02.

  112. 8-K

    Medtronic plc published results

    Form 8-K, item 2.02.

  113. 8-K

    MongoDB, Inc. published results

    Form 8-K, item 2.02.

  114. 8-K

    MiniMed Group, Inc. published results

    Form 8-K, items 2.02, 7.01. Also made a Regulation FD disclosure.

  115. 8-K

    Sportsman'S Warehouse Holdings, Inc. published results

    Form 8-K, item 2.02.

  116. 8-K

    Yext, Inc. published results

    Form 8-K, item 2.02.

  117. 8-K

    Palo Alto Networks Inc published results

    Form 8-K, item 2.02.

  118. 8-K

    Credo Technology Group Holding Ltd published results

    Form 8-K, item 2.02.

  119. 8-K

    Albany International Corp /DE/ published results

    Form 8-K, items 2.02, 7.01. Also made a Regulation FD disclosure.

  120. 8-K

    Dell Technologies Inc. published results

    Form 8-K, item 2.02.

  121. 8-K

    Interactive Strength, Inc. reported shareholder vote results

    Form 8-K, item 5.07.

  122. Stake 13G

    New passive stake of 5% or more

    Schedule 13G naming Universe Pharmaceuticals INC and Yang Lu (nmn).

  123. Stake 13G

    New passive stake of 5% or more

    Schedule 13G naming Tang Chengming and Universe Pharmaceuticals INC.

  124. Stake 13G

    New passive stake of 5% or more

    Schedule 13G naming Universe Pharmaceuticals INC and Ye Piao.

  125. Stake 13G

    New passive stake of 5% or more

    Schedule 13G naming Universe Pharmaceuticals INC and Xie Shan.

  126. Stake 13G

    New passive stake of 5% or more

    Schedule 13G naming KCM Capital Inc and New ERA Energy & Digital, Inc.

  127. Stake 13G

    New passive stake of 5% or more

    Schedule 13G naming Divisadero Street Capital Management, LP and Rush Street Interactive, Inc.

  128. Stake 13G

    New passive stake of 5% or more

    Schedule 13G naming Universe Pharmaceuticals INC and Zheng Chunhua.

  129. Stake 13G

    New passive stake of 5% or more

    Schedule 13G naming MMCAP International Inc. SPC and Rainier Acquisition Corp.

  130. Stake 13G

    New passive stake of 5% or more

    Schedule 13G naming Li Xuefeng and Universe Pharmaceuticals INC.

  131. Stake 13G

    New passive stake of 5% or more

    Schedule 13G naming Fortress Biotech, Inc. and Integrated Core Strategies (US) LLC.

  132. Stake 13G

    New passive stake of 5% or more

    Schedule 13G naming Chen Xuncheng and Universe Pharmaceuticals INC.

  133. Stake 13G

    New passive stake of 5% or more

    Schedule 13G naming Freenome, Inc. and Roche Holdings Inc.

  134. Stake 13G

    New passive stake of 5% or more

    Schedule 13G naming Lu Shanshan and Universe Pharmaceuticals INC.

  135. 8-K

    Earth Science Tech, Inc. reported shareholder vote results

    Form 8-K, items 5.07, 7.01. Also made a Regulation FD disclosure.

  136. 8-K

    AB Commercial Real Estate Private Debt Fund, LLC reported shareholder vote results

    Form 8-K, item 5.07.

  137. 8-K

    Capital Southwest Corp reported shareholder vote results

    Form 8-K, items 5.03, 5.07, 7.01. Also amended its articles or bylaws; made a Regulation FD disclosure.

  138. 8-K

    BiomX Inc. amended its articles or bylaws

    Form 8-K, items 5.03, 8.01. Also reported other events.

  139. 8-K

    Capital One Financial Corp amended its articles or bylaws

    Form 8-K, item 5.03.

  140. Offering

    Entrata, Inc. amended its share registration

    Form S-1/A, amended registration statement.

  141. Offering

    Cyabra, Inc. amended its share registration

    Form S-1/A, amended registration statement.

  142. Stake 13G

    Updated passive stake of 5% or more

    Schedule 13G/A naming Advent International, L.P. and NCS Multistage Holdings, Inc.

  143. Stake 13G

    Updated passive stake of 5% or more

    Schedule 13G/A naming Bluemount Holdings Ltd and Luk Tung Lam.

  144. Stake 13G

    Updated passive stake of 5% or more

    Schedule 13G/A naming L1 Capital Global Opportunities Master Fund, Ltd. and Zeta Network Group.

  145. Stake 13G

    Updated passive stake of 5% or more

    Schedule 13G/A naming Agarwal Amit Mohan and biote Corp.

  146. Stake 13G

    Updated passive stake of 5% or more

    Schedule 13G/A naming Helikon Investments Ltd and New Pacific Metals Corp.

  147. Stake 13G

    Updated passive stake of 5% or more

    Schedule 13G/A naming South32 Ltd and Trilogy Metals Inc.

  148. Proxy

    Acurx Pharmaceuticals, Inc. filed its proxy statement for a shareholder meeting

    Schedule 14A.

  149. Proxy

    Aethlon Medical Inc filed its proxy statement for a shareholder meeting

    Schedule 14A.

  150. Proxy

    Pacer Funds Trust filed its proxy statement for a shareholder meeting

    Schedule 14A.

  151. Insider trades

    518 insider-trade forms filed by directors and major holders

    Shown as a count until Loro reads the transactions inside them: who bought or sold, how many shares, at what price. Most filings: CPI Card Group Inc. (16), NCS Multistage Holdings, Inc. (12), Crinetics Pharmaceuticals, Inc. (11), Bandwidth Inc. (9), BLACKBERRY Ltd (7), Fuller H B Co (7).

    SEC Form 4

Showing the 150 most material of 265.